High glucose induces podocyte injury via enhanced (Pro)renin receptor-Wnt-β-catenin-snail signaling pathway

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Li, Caixia ^a   Siragy, Helmy M ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CATENIN; F ACTIN; GLUCOSE; MESSENGER RNA; NEPHRIN; PODOCIN; PRORENIN RECEPTOR; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR SNAIL; WNT PROTEIN; WNT3A PROTEIN; BETA CATENIN; CELL SURFACE RECEPTOR; SNAIL FAMILY TRANSCRIPTION FACTORS; SWEETENING AGENT; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DAMAGE; CELL MEMBRANE PERMEABILITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOSKELETON; MOUSE; NONHUMAN; PODOCYTE; PROTEIN EXPRESSION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; ANIMAL; DRUG EFFECTS; ENZYME IMMUNOASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; BETA CATENIN; BLOTTING, WESTERN; CELLS, CULTURED; FLUORESCENT ANTIBODY TECHNIQUE; GLUCOSE; IMMUNOENZYME TECHNIQUES; MICE; PODOCYTES; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CELL SURFACE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; SWEETENING AGENTS; TRANSCRIPTION FACTORS; WNT PROTEINS;

EID: 84895755579     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089233     Document Type: Article

References (49)

1. Covington MD, Schnellmann RG (2012) Chronic high glucose downregulates mitochondrial calpain 10 and contributes to renal cell death and diabetes-induced renal injury. Kidney Int 81: 391-400.
2. Fox CS, Matsushita K, Woodward M, Bilo HJ, Chalmers J, et al. (2012) Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet 380: 1662-1673.
3. Leeuwis JW, Nguyen TQ, Dendooven A, Kok RJ, Goldschmeding R (2010) Targeting podocyte-associated diseases. Adv Drug Deliv Rev 62: 1325-1336.
4. Li CX, Xia M, Han WQ, Li XX, Zhang C, et al. (2011) Reversal by growth hormone of homocysteine-induced epithelial-to-mesenchymal transition through membrane raft-redox signaling in podocytes. Cell Physiol Biochem 27: 691-702.
5. Riediger F, Quack I, Qadri F, Hartleben B, Park JK, et al. (2011) Prorenin receptor is essential for podocyte autophagy and survival. J Am Soc Nephrol 22: 2193-2202.
6. Tryggvason K, Patrakka J, Wartiovaara J (2006) Hereditary proteinuria syndromes and mechanisms of proteinuria. N Engl J Med 354: 1387-1401.
7. Coimbra TM, Janssen U, Grone HJ, Ostendorf T, Kunter U, et al. (2000) Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes. Kidney Int 57: 167-182. (Pubitemid 30227764)
8. Siu B, Saha J, Smoyer WE, Sullivan KA, Brosius FC, 3rd (2006) Reduction in podocyte density as a pathologic feature in early diabetic nephropathy in rodents: prevention by lipoic acid treatment. BMC Nephrol 7: 6.
9. Xue C, Siragy HM (2005) Local renal aldosterone system and its regulation by salt, diabetes, and angiotensin II type 1 receptor. Hypertension 46: 584-590. (Pubitemid 41379384)
10. Carey RM, Siragy HM (2003) The intrarenal renin-angiotensin system and diabetic nephropathy. Trends Endocrinol Metab 14: 274-281. (Pubitemid 36992197)
11. Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, et al. (2001) Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345: 861-869.
12. Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, et al. (2001) Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345: 851-860.
13. Nguyen G, Delarue F, Burckle C, Bouzhir L, Giller T, et al. (2002) Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest 109: 1417-1427. (Pubitemid 34596167)
14. Nguyen G, Contrepas A (2008) Physiology and pharmacology of the (pro)renin receptor. Curr Opin Pharmacol 8: 127-132.
15. Sihn G, Rousselle A, Vilianovitch L, Burckle C, Bader M (2010) Physiology of the (pro)renin receptor: Wnt of change? Kidney Int 78: 246-256.
16. Huang J, Siragy HM (2009) Glucose promotes the production of interleukine-1beta and cyclooxygenase-2 in mesangial cells via enhanced (Pro)renin receptor expression. Endocrinology 150: 5557-5565.
17. Advani A, Kelly DJ, Cox AJ, White KE, Advani SL, et al. (2009) The (Pro)renin receptor: site-specific and functional linkage to the vacuolar H+-ATPase in the kidney. Hypertension 54: 261-269.
18. Cheng H, Fan X, Moeckel GW, Harris RC (2011) Podocyte COX-2 exacerbates diabetic nephropathy by increasing podocyte (pro)renin receptor expression. J Am Soc Nephrol 22: 1240-1251.
19. Siragy HM, Huang J (2008) Renal (pro)renin receptor upregulation in diabetic rats through enhanced angiotensin AT1 receptor and NADPH oxidase activity. Exp Physiol 93: 709-714. (Pubitemid 351595048)
20. Huang Y, Wongamorntham S, Kasting J, McQuillan D, Owens RT, et al. (2006) Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms. Kidney Int 69: 105-113. (Pubitemid 43117745)
21. Ichihara A, Sakoda M, Kurauchi-Mito A, Narita T, Kinouchi K, et al. (2009) Drug discovery for overcoming chronic kidney disease (CKD): new therapy for CKD by a (pro)renin-receptor-blocking decoy peptide. J Pharmacol Sci 109: 20-23.
22. Gonzalez AA, Luffman C, Bourgeois CR, Vio CP, Prieto MC (2013) Angiotensin II-independent upregulation of cyclooxygenase-2 by activation of the (Pro)renin receptor in rat renal inner medullary cells. Hypertension 61: 443-449.
23. Huang J, Siragy HM (2010) Regulation of (pro)renin receptor expression by glucose-induced mitogen-activated protein kinase, nuclear factor-kappaB, and activator protein-1 signaling pathways. Endocrinology 151: 3317-3325.
24. Nelson WJ, Nusse R (2004) Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303: 1483-1487. (Pubitemid 38314410)
25. Philipp I, Aufschnaiter R, Ozbek S, Pontasch S, Jenewein M, et al. (2009) Wnt/beta-catenin and noncanonical Wnt signaling interact in tissue evagination in the simple eumetazoan Hydra. Proc Natl Acad Sci U S A 106: 4290-4295.
26. Gaston-Massuet C, Andoniadou CL, Signore M, Jayakody SA, Charolidi N, et al. (2011) Increased Wingless (Wnt) signaling in pituitary progenitor/stem cells gives rise to pituitary tumors in mice and humans. Proc Natl Acad Sci U S A 108: 11482-11487.
27. Clevers H, Nusse R (2012) Wnt/beta-catenin signaling and disease. Cell 149: 1192-1205.
28. Wang D, Dai C, Li Y, Liu Y (2011) Canonical Wnt/beta-catenin signaling mediates transforming growth factor-beta1-driven podocyte injury and proteinuria. Kidney Int 80: 1159-1169.
29. Clevers H (2006) Wnt/beta-catenin signaling in development and disease. Cell 127: 469-480.
30. van Amerongen R, Mikels A, Nusse R (2008) Alternative wnt signaling is initiated by distinct receptors. Sci Signal 1: re9.
31. Kuhl M, Sheldahl LC, Park M, Miller JR, Moon RT (2000) The Wnt/Ca2+ pathway: a new vertebrate Wnt signaling pathway takes shape. Trends Genet 16: 279-283. (Pubitemid 30389591)
32. Hsu RJ, Ho JY, Cha TL, Yu DS, Wu CL, et al. (2012) WNT10A plays an oncogenic role in renal cell carcinoma by activating WNT/beta-catenin pathway. PLoS One 7: e47649.
33. Ueno K, Hirata H, Majid S, Tabatabai ZL, Hinoda Y, et al. (2011) IGFBP-4 activates the Wnt/beta-catenin signaling pathway and induces M-CAM expression in human renal cell carcinoma. Int J Cancer 129: 2360-2369.
34. Pulkkinen K, Murugan S, Vainio S (2008) Wnt signaling in kidney development and disease. Organogenesis 4: 55-59. (Pubitemid 351881300)
35. Nelson PJ, von Toerne C, Grone HJ (2011) Wnt-signaling pathways in progressive renal fibrosis. Expert Opin Ther Targets 15: 1073-1083.
36. Wuebken A, Schmidt-Ott KM (2011) WNT/beta-catenin signaling in polycystic kidney disease. Kidney Int 80: 135-138.
37. Terada Y, Tanaka H, Okado T, Shimamura H, Inoshita S, et al. (2003) Expression and function of the developmental gene Wnt-4 during experimental acute renal failure in rats. J Am Soc Nephrol 14: 1223-1233. (Pubitemid 36514664)
38. Kato H, Gruenwald A, Suh JH, Miner JH, Barisoni-Thomas L, et al. (2011) Wnt/beta-catenin pathway in podocytes integrates cell adhesion, differentiation, and survival. J Biol Chem 286: 26003-26015.
39. Cruciat CM, Ohkawara B, Acebron SP, Karaulanov E, Reinhard C, et al. (2010) Requirement of prorenin receptor and vacuolar H+-ATPase-mediated acidification for Wnt signaling. Science 327: 459-463.
40. Oshima Y, Kinouchi K, Ichihara A, Sakoda M, Kurauchi-Mito A, et al. (2011) Prorenin receptor is essential for normal podocyte structure and function. J Am Soc Nephrol 22: 2203-2212.
41. Dai C, Stolz DB, Kiss LP, Monga SP, Holzman LB, et al. (2009) Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria. J Am Soc Nephrol 20: 1997-2008.
42. Waters A, Koziell A (2009) Activation of canonical Wnt signaling meets with podocytopathy. J Am Soc Nephrol 20: 1864-1866.
43. Katoh M (2006) Cross-talk of WNT and FGF signaling pathways at GSK3beta to regulate beta-catenin and SNAIL signaling cascades. Cancer Biol Ther 5: 1059-1064.
44. Matsui I, Ito T, Kurihara H, Imai E, Ogihara T, et al. (2007) Snail, a transcriptional regulator, represses nephrin expression in glomerular epithelial cells of nephrotic rats. Lab Invest 87: 273-283. (Pubitemid 46353945)
45. Ikenouchi J, Matsuda M, Furuse M, Tsukita S (2003) Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail. J Cell Sci 116: 1959-1967. (Pubitemid 36622294)
46. Boutet A, De Frutos CA, Maxwell PH, Mayol MJ, Romero J, et al. (2006) Snail activation disrupts tissue homeostasis and induces fibrosis in the adult kidney. EMBO J 25: 5603-5613. (Pubitemid 44847200)
47. Schwartz EJ, Cara A, Snoeck H, Ross MD, Sunamoto M, et al. (2001) Human immunodeficiency virus-1 induces loss of contact inhibition in podocytes. J Am Soc Nephrol 12: 1677-1684. (Pubitemid 32674430)
48. Awad AS, Rouse M, Liu L, Vergis AL, Rosin DL, et al. (2008) Activation of adenosine 2A receptors preserves structure and function of podocytes. J Am Soc Nephrol 19: 59-68.
49. Li Y, Kang YS, Dai C, Kiss LP, Wen X, et al. (2008) Epithelial-to- mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria. Am J Pathol 172: 299-308. (Pubitemid 351282018)